310 related articles for article (PubMed ID: 28750194)
1. Ketoacidosis alone does not predispose to mucormycosis by Lichtheimia in a murine pulmonary infection model.
Schulze B; Rambach G; Schwartze VU; Voigt K; Schubert K; Speth C; Jacobsen ID
Virulence; 2017 Nov; 8(8):1657-1667. PubMed ID: 28750194
[TBL] [Abstract][Full Text] [Related]
2. Comparative immunopathogenesis in a murine model of inhalative infection with the mucormycetes Lichtheimia corymbifera and Rhizopus arrhizus.
Rambach G; Fleischer V; Harpf V; Lackner M; Meinitzer A; Maier H; Engesser J; Lass-Flörl C; Speth C
PLoS One; 2020; 15(6):e0234063. PubMed ID: 32555589
[TBL] [Abstract][Full Text] [Related]
3. First Case of Rhinocerebral Mucormycosis Caused by Lichtheimia ornata, with a Review of Lichtheimia Infections.
Pan J; Tsui C; Li M; Xiao K; de Hoog GS; Verweij PE; Cao Y; Lu H; Jiang Y
Mycopathologia; 2020 Jun; 185(3):555-567. PubMed ID: 32388712
[TBL] [Abstract][Full Text] [Related]
4. Lichtheimia species exhibit differences in virulence potential.
Schwartze VU; Hoffmann K; Nyilasi I; Papp T; Vágvölgyi C; de Hoog S; Voigt K; Jacobsen ID
PLoS One; 2012; 7(7):e40908. PubMed ID: 22911715
[TBL] [Abstract][Full Text] [Related]
5. Adaptation to thermotolerance in Rhizopus coincides with virulence as revealed by avian and invertebrate infection models, phylogeny, physiological and metabolic flexibility.
Kaerger K; Schwartze VU; Dolatabadi S; Nyilasi I; Kovács SA; Binder U; Papp T; Hoog Sd; Jacobsen ID; Voigt K
Virulence; 2015; 6(4):395-403. PubMed ID: 26065324
[TBL] [Abstract][Full Text] [Related]
6. Mucormycoses caused by Lichtheimia species.
Schwartze VU; Jacobsen ID
Mycoses; 2014 Dec; 57 Suppl 3():73-8. PubMed ID: 25186921
[TBL] [Abstract][Full Text] [Related]
7. Mucormycosis--from the pathogens to the disease.
Binder U; Maurer E; Lass-Flörl C
Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():60-6. PubMed ID: 24476149
[TBL] [Abstract][Full Text] [Related]
8. Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.
Petraitis V; Petraitiene R; Antachopoulos C; Hughes JE; Cotton MP; Kasai M; Harrington S; Gamaletsou MN; Bacher JD; Kontoyiannis DP; Roilides E; Walsh TJ
Med Mycol; 2013 Jan; 51(1):72-82. PubMed ID: 22686246
[TBL] [Abstract][Full Text] [Related]
9. Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis.
Gebremariam T; Alkhazraji S; Soliman SSM; Gu Y; Jeon HH; Zhang L; French SW; Stevens DA; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
Sci Adv; 2019 Jun; 5(6):eaaw1327. PubMed ID: 31206021
[TBL] [Abstract][Full Text] [Related]
10. CotH3 mediates fungal invasion of host cells during mucormycosis.
Gebremariam T; Liu M; Luo G; Bruno V; Phan QT; Waring AJ; Edwards JE; Filler SG; Yeaman MR; Ibrahim AS
J Clin Invest; 2014 Jan; 124(1):237-50. PubMed ID: 24355926
[TBL] [Abstract][Full Text] [Related]
11. Gene expansion shapes genome architecture in the human pathogen Lichtheimia corymbifera: an evolutionary genomics analysis in the ancient terrestrial mucorales (Mucoromycotina).
Schwartze VU; Winter S; Shelest E; Marcet-Houben M; Horn F; Wehner S; Linde J; Valiante V; Sammeth M; Riege K; Nowrousian M; Kaerger K; Jacobsen ID; Marz M; Brakhage AA; Gabaldón T; Böcker S; Voigt K
PLoS Genet; 2014 Aug; 10(8):e1004496. PubMed ID: 25121733
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of EGFR Signaling Protects from Mucormycosis.
Watkins TN; Gebremariam T; Swidergall M; Shetty AC; Graf KT; Alqarihi A; Alkhazraji S; Alsaadi AI; Edwards VL; Filler SG; Ibrahim AS; Bruno VM
mBio; 2018 Aug; 9(4):. PubMed ID: 30108171
[TBL] [Abstract][Full Text] [Related]
13. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
Maurer E; Hörtnagl C; Lackner M; Grässle D; Naschberger V; Moser P; Segal E; Semis M; Lass-Flörl C; Binder U
Med Mycol; 2019 Apr; 57(3):351-362. PubMed ID: 29924357
[TBL] [Abstract][Full Text] [Related]
14. GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis.
Alqarihi A; Gebremariam T; Gu Y; Swidergall M; Alkhazraji S; Soliman SSM; Bruno VM; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
mBio; 2020 Jun; 11(3):. PubMed ID: 32487760
[TBL] [Abstract][Full Text] [Related]
15. Mucormycosis in India: unique features.
Chakrabarti A; Singh R
Mycoses; 2014 Dec; 57 Suppl 3():85-90. PubMed ID: 25187095
[TBL] [Abstract][Full Text] [Related]
16. Lichtheimia hongkongensis sp. nov., a novel Lichtheimia spp. associated with rhinocerebral, gastrointestinal, and cutaneous mucormycosis.
Woo PC; Lau SK; Ngan AH; Tung ET; Leung SY; To KK; Cheng VC; Yuen KY
Diagn Microbiol Infect Dis; 2010 Mar; 66(3):274-84. PubMed ID: 20159375
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroids alter alveolar macrophage control of Lichtheimia corymbifera spores in an ex vivo mouse model.
Brunet K; Arrivé F; Martellosio JP; Lamarche I; Marchand S; Rammaert B
Med Mycol; 2021 Jul; 59(7):694-700. PubMed ID: 33369666
[TBL] [Abstract][Full Text] [Related]
18. The TLR-NF-kB axis contributes to the monocytic inflammatory response against a virulent strain of
Montaño DE; Hartung S; Wich M; Ali R; Jungnickel B; von Lilienfeld-Toal M; Voigt K
Front Immunol; 2022; 13():882921. PubMed ID: 36311802
[TBL] [Abstract][Full Text] [Related]
19. A case of COVID-19-associated mucormycosis due to Lichtheimia ramosa.
Aboutalebian S; Erami M; Momen-Heravi M; Charsizadeh A; Hezaveh SJH; Matini AH; Ahsaniarani AH; Fakhrehi M; Mirhendi H
J Clin Lab Anal; 2023 Apr; 37(8):e24895. PubMed ID: 37183276
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
Bala K; Chander J; Handa U; Punia RS; Attri AK
Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
